Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

August Update: Possible Link Between Hepatitis C Drugs & Liver Cancer

September 1, 2017 By Law Offices of Thomas J. Lamb, P.A.

In the past several years, there has been much controversy surrounding the possible link between a class of Hepatitis C drugs known as direct-acting antivirals (DAAs) and hepatocellular carcinoma (HCC), or liver cancer.  The DAA drugs include Harvoni, Sovaldi, Viekira Pak, Technivie, Olysio, Daklinza, Epclusa, and Zepatier. In July, I wrote an … [Read more...]

Filed Under: Unsafe Drugs Tagged With: daa drugs, Daklinza, direct-acting antivirals, drugs side effects, Epclusa, Harvoni, hcc, hepatitis c drugs, hepatocellular carcinoma, Liver Cancer, liver cancer causes, Olysio, Sovaldi, Technivie, Viekira Pak, Zepatier

Can Hepatitis C Drugs Harvoni Or Sovaldi Cause Return Of Liver Cancer?

May 2, 2017 By Law Offices of Thomas J. Lamb, P.A.

In April 2017 this news report, “The Link Between Direct-Acting Antiviral Therapy for Hepatitis C Virus and Liver Cancer Risk Continues To Be Debated”, was published on the PracticeUpdate website. This recent report draws upon eight new medical studies which were presented at the International Liver Congress 2017, from April 19 to 23, 2017, in … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Daklinza, Epclusa, Harvoni, Liver Cancer, Olysio, Sovaldi, Technivie, Viekira Pak, Zepatier

Safety of Hepatitis C Treatment Drugs Called Into Question

January 30, 2017 By Law Offices of Thomas J. Lamb, P.A.

UPDATE:  On February 14, 2017, the FDA released a Black Box warning for these drugs with the following text:Hepatitis B virus (HBV) reactivation has been reported, in some cases resulting in fulminant hepatitis, hepatic failure, and death.(2/16/17).Recently, the safety of the newer hepatitis C treatment drugs -- such as Solvadi and Harvoni -- is … [Read more...]

Filed Under: Uncategorized Tagged With: daclatasvir, Daklinza, dasabuvir, direct-acting antiviral drugs, drug injury, drug side effects, elbasvir, Epclusa, grazoprevir, Harvoni, hepatitis b reactivation, hepatitis c treatment drugs, Institute for Safe Medication Practices, lawsuits, ledipasvir, liver damage, liver failure, liver injury, Olysio, ombitasvir, paritaprevir, ritonavir, simeprevir, sofosbuvir, Sovaldi, Technivie, velpatasvir, Viekira Pak, Zepatier

Black-Box Warning For Harvoni, Sovaldi, Viekira Pak: Hepatitis B Risk

October 7, 2016 By Law Offices of Thomas J. Lamb, P.A.

Direct-acting antivirals (DAAs) are a class of prescription medicines that are FDA-approved to treat adults with hepatitis C virus (HCV) infection. These medicines are available as single-ingredient products and also in combination with other HCV medicines. Here is a list of direct-acting antivirals currently available in the US: Daklinza … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Daklinza, Epclusa, Harvoni, Hepatitis, Olysio, Sovaldi, Technivie, Viekira Pak, Zepatier

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.